← FDA Drug Approvals (Drugs@FDA)

SPIRONOLACTONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2025-02-21

Drug application

FDA Application #

ANDA218085

Application type

Abbreviated New Drug Application (Generic)

Brand name

SPIRONOLACTONE

Generic name

SPIRONOLACTONE

Active ingredients

SPIRONOLACTONE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2025-02-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown